COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at revolutionizing precision medicine across Texas Oncology’s community cancer centers. Leveraging COTA’s AI-powered curation engine, CAILIN™, this collaboration will transform fragmented healthcare data into actionable insights.
Unlocking Insights from Electronic Health Records (EHRs)
Electronic health records contain a comprehensive account of a patient’s cancer care journey. However, their unstructured and incomplete format poses challenges for analysis. By infusing AI into data processing, COTA and PHI aim to accelerate precision medicine at the point of care.
Also Read: Circle Cardiovascular Imaging Announces Leadership Transition
High-Quality Data as the Foundation
Lori Brisbin, chief operating officer of Precision Health Informatics, emphasizes the importance of clean, accurate data: “As we invest in AI, a solid data foundation is crucial. COTA’s AI-powered curation engine enables Texas Oncology to derive meaningful insights and deliver personalized care to patients.”
Generative AI and Real-World Data
Dr. C.K. Wang, chief medical officer at COTA, highlights the promise of generative AI: “By meshing automation and supervision of high-quality real-world data (RWD), COTA is changing the dynamics of cancer care.”
Source: Businesswire
